Clinical Trial Update: P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy, being studied in advanced or metastatic solid tumors. The study is currently Active, no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma
• Nasopharyngeal Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma

Drugs mentioned

• P-MUC1C-ALLO1

Snippet

Sponsor: Poseida Therapeutics, Inc. | Conditions: Breast Cancer, Ovarian Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING